Literature DB >> 10422198

Cytokines in viral hepatitis.

M J Koziel1.   

Abstract

Cytokines play an important role in the defense against viral infections, both indirectly, through determination of the predominant pattern of host response, and directly, through inhibition of viral replication. However, in the context of an inflammatory response against a virus, cytokines may also lead to liver damage. The importance of this is best demonstrated in hepatitis B virus (HBV). In acute HBV infection, a vigorous polyclonal cellular immune response is critical; thus type 1 cytokine release is essential to initiating an effective immune response. The cytokines released by CD4+ and CD8+ cells also play an important role in downregulation of HBV replication, demonstrating that it is possible to control a viral infection without the death of infected cells. However, if there is a defect in the acute response, HBV becomes chronic; in that case, the presence of an ongoing suboptimal inflammatory response can activate the process of hepatic fibrosis. In hepatitis C infection, the role of cellular immune responses and cytokines is less clear. Hepatitis C may be resistant to inhibition by cytokines, so cytokines may have a more prominent role in liver damage than in controlling viral replication. Both hepatitis B and C may have specific mechanisms to inhibit cytokine production, highlighting the critical role of these molecules in recovery from infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422198     DOI: 10.1055/s-2007-1007107

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  48 in total

1.  Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.

Authors:  Filiz Akyüz; Nuray Polat; Sabahattin Kaymakoglu; Nevzat Aksoy; Kadir Demir; Fatih Beşişik; Selim Badur; Yilmaz Cakaloglu; Atilla Okten
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Polymorphisms of interleukin-1R receptor antagonist genes in patients with chronic hepatitis B in Iran.

Authors:  Mitra Ranjbar; Amir Houshang Mohammad Alizadeh; Mehrdad Hajiloi; Seyed Mohsen Mousavi
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

3.  Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India.

Authors:  Rajesh Panigrahi; Neelakshi Sarkar; Avik Biswas; Ananya Pal; Debraj Saha; Shivaram P Singh; Manas K Panigrahi; Manikanana Bandopadhyay; Sekhar Chakrabarti; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2014-09-18

Review 4.  Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Authors:  Giada Sebastiani; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

5.  Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B.

Authors:  Nusret Akpolat; Seyfettin Yahsi; Ahmet Godekmerdan; Kutbettin Demirbag; Mehmet Yalniz
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  Effects of interferon-alpha subtypes on the TH1/TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders.

Authors:  Toshio Ariyasu; Takeshi Tanaka; Noboru Fujioka; Yoshiaki Yanai; Shigeto Yamamoto; Hiroshi Yamauchi; Hakuo Ikegami; Masao Ikeda; Masashi Kurimoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Jan-Feb       Impact factor: 2.416

7.  Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.

Authors:  Camilla S Graham; Annalee Wells; Tun Liu; Kenneth E Sherman; Marion Peters; Raymond T Chung; Atul K Bhan; Janet Andersen; Margaret James Koziel
Journal:  AIDS       Date:  2005-05-20       Impact factor: 4.177

Review 8.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

9.  Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.

Authors:  Curtis Cooper; Stephan Shafran; Susan Greenbloom; Robert Enns; John Farley; Nir Hilzenrat; Kurt Williams; Magdy Elkashab; Nabil Abadir; Manuela Neuman
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-08

Review 10.  Pathogenic interactions between alcohol and hepatitis C.

Authors:  Gyongyi Szabo
Journal:  Curr Gastroenterol Rep       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.